Full-Time

GMP Operational Quality Manager

Confirmed live in the last 24 hours

Vertex Pharmaceuticals

Vertex Pharmaceuticals

1,001-5,000 employees

Develops medicines for serious diseases

Compensation Overview

$115.9k - $173.8k/yr

+ Bonus + Equity Awards

Senior

Company Does Not Provide H1B Sponsorship

Boston, MA, USA

3 days onsite and 2 days flexible

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • In-depth knowledge of both the conceptual and practical application of cGMPs in a pharmaceutical setting; in-depth knowledge of global GMP requirements and support of GMP manufacturing.
  • Strong team leadership skills with the ability to work in a fast-paced environment and meet quality, accuracy and timeliness objectives.
  • Experience leading complex projects/teams and continuous improvement initiatives within stated objectives and timelines; effectively applies project management processes/tools to lead meetings, assist with project planning, and facilitate completion of tasks.
  • Ability to independently lead cross-functional teams and represent the Quality unit.
  • Ability to mentor and guide staff, skilled at transferring technical knowledge and teaching quality management skills.
  • Ability to communicate cross-functionally to a wide variety of audiences; exchanges complex and sensitive information and is able to influence others to understand a point of view and gain alignment around a proposed action.
  • Demonstrated ability to work independently to provide QA advice for large, multifaceted projects.
  • Demonstrated ability to evaluate quality matters and make complex decisions leveraging technical experience, advanced judgement and the analysis/synthesis of a variety of information; able to work outside of precedent and takes a new perspective on existing solutions.
  • Strong experience successfully leading event investigations, Root Cause Analysis (RCA), and CAPA.
  • Strong experience with electronic document management systems (e.g., Veeva).
  • Bachelor’s degree in a scientific or allied health field with 5+ years of relevant work experience, or the equivalent combination of education and experience.
  • Experience providing Quality support and oversight of GMP manufacturing operation including batch disposition.
  • Experience with drug substance, spray dried dispersion (SDD) and drug product (oral solid dosage forms preferred) development and manufacturing with proficient knowledge in a pharmaceutical setting.
  • Knowledge of cGMP requirements governing oral drug products manufacturing practices.
Responsibilities
  • Participates in cross-functional teams as a Quality technical resource responsible for providing quality oversight and support to manufacturing operations at contracted suppliers.
  • Drafts and enforces Quality Agreements between CMOs/Suppliers and Vertex, as needed.
  • Assists Change Control owners with ensuring compliance to change procedure requirements, assesses and approves change controls.
  • Conducts quality investigations/deviations and reviews corrective action plans for adequacy and compliance. This includes root cause analysis and product impact assessments for investigations resulting from deviations and OOS.
  • Ensures appropriate CAPA actions are identified and addressed.
  • Approves investigations/CAPAs.
  • Identify, facilitate, and/or lead continuous improvement efforts.
  • Maintains quality metrics to support process improvement activities.
  • Conducts GMP document review, including procedures, work instructions, specifications, methods, protocols, and method reports.
  • Performs disposition activities in support of Commercial products.
  • Responsible for coordinating, facilitating and follow up on any QLT action items assigned.
  • Identify and communicate risks and assist with risk mitigation plans as necessary.
  • Supports internal audit or external audit programs.
  • Assists in preparation of audit responses.
  • Manages audit CAPAs & metrics.
  • Provides technical advice for partner and regulatory agency audits.
Desired Qualifications
  • Experience with drug substance, spray dried dispersion (SDD) and drug product (oral solid dosage forms preferred) development and manufacturing with proficient knowledge in a pharmaceutical setting.
Vertex Pharmaceuticals

Vertex Pharmaceuticals

View

Vertex Pharmaceuticals develops medicines for serious diseases, focusing on conditions like cystic fibrosis. The company conducts extensive research and development to create new drugs, often collaborating with other biotech firms to enhance its therapeutic offerings. One of its notable products is ivacaftor, which has shown effectiveness in treating cystic fibrosis. Vertex differentiates itself from competitors through its commitment to scientific innovation and strategic partnerships that expand its research capabilities. The goal of Vertex Pharmaceuticals is to improve the quality of life for patients with severe and life-threatening conditions by bringing effective treatments to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Boston, Massachusetts

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • Vertex's EU approval expands its cystic fibrosis treatment market.
  • Partnerships with Arbor and Orna enhance Vertex's gene therapy capabilities.
  • Increased focus on personalized medicine aligns with Vertex's patient-centric approach.

What critics are saying

  • Increased competition in cystic fibrosis could impact Vertex's market share.
  • Regulatory changes in the EU may delay Vertex's drug approvals.
  • High R&D costs and potential trial failures could strain Vertex's finances.

What makes Vertex Pharmaceuticals unique

  • Vertex focuses on transformative medicines for serious diseases, like cystic fibrosis.
  • The company invests heavily in R&D and strategic partnerships for drug development.
  • Vertex's innovative cell and gene therapies set it apart in the biotech industry.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Company News

Buniversity
May 1st, 2025
VERTEX upset Grayhound for spot at BLAST Showdown

VERTEX locked in a first-place finish at Fortress OCE Masters Fall 2022 Finals in Melbourne to qualify for BLAST Premier Fall Showdown.

BioSpace
Apr 14th, 2025
Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis

Vertex researcher, Paul Negulescu Ph.D., receives the 2025 Canada Gairdner International Award for pioneering Research and discovery of medicines for Cystic Fibrosis.

Biz Owner Daily
Apr 7th, 2025
EU Approves Expanded Label for Vertex Pharmaceuticals' Cystic Fibrosis Treatment

Vertex Pharmaceuticals has received approval from the European Union to broaden the label for its cystic fibrosis treatment.

Slater Sentinel
Mar 23rd, 2025
Stevens Capital Management LP Makes New $829,000 Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Stevens Capital Management LP makes new $829,000 investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX).

Investing.com
Mar 20th, 2025
BMO maintains Vertex stock Market Perform rating and $41 target

The reaffirmation of the rating and target came after Vertex held its first analyst day since its initial public offering in 2020.